Montag A & Associates Inc. raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 911.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,150 shares of the medical research company's stock after buying an additional 11,850 shares during the period. Montag A & Associates Inc.'s holdings in Agilent Technologies were worth $1,750,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Bayforest Capital Ltd raised its stake in Agilent Technologies by 57.0% during the 2nd quarter. Bayforest Capital Ltd now owns 832 shares of the medical research company's stock valued at $111,000 after purchasing an additional 302 shares during the period. North Dakota State Investment Board grew its stake in shares of Agilent Technologies by 2.9% during the second quarter. North Dakota State Investment Board now owns 8,473 shares of the medical research company's stock valued at $1,125,000 after buying an additional 237 shares during the last quarter. VCI Wealth Management LLC grew its holdings in shares of Agilent Technologies by 70.5% in the second quarter. VCI Wealth Management LLC now owns 22,020 shares of the medical research company's stock worth $2,925,000 after purchasing an additional 9,105 shares during the last quarter. LFG Wealth Partners LLC purchased a new position in Agilent Technologies during the 2nd quarter worth $1,750,000. Finally, 111 Capital purchased a new stake in Agilent Technologies during the second quarter worth $1,253,000.
Agilent Technologies Stock Down 0.5%
Shares of NYSE:A opened at $148.55 on Friday. The stock has a market cap of $41.95 billion, a price-to-earnings ratio of 29.83, a price-to-earnings-growth ratio of 2.63 and a beta of 1.25. The firm's 50 day moving average price is $135.38 and its 200 day moving average price is $125.56. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.
Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter in the previous year, the business earned $1.31 earnings per share. The firm's revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.
Agilent Technologies Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies's dividend payout ratio is presently 20.48%.
Wall Street Analyst Weigh In
Several brokerages recently commented on A. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price objective for the company. Wolfe Research reiterated a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. HSBC cut their price target on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Sunday, August 2nd. Finally, Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $160.24.
Read Our Latest Stock Analysis on Agilent Technologies
Agilent Technologies Profile
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
